Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptidomimetics and angiogenesis.

Ralph Mazitschek1, Patrick Baumhof, Athanassios Giannis

  • 1Institut für Organische Chemie der Universität Leipzig, Johannisallee 29, D-04103 Leipzig, Germany.

Mini Reviews in Medicinal Chemistry
|October 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma.

Nature chemical biology·2026
Same author

Proximity-Induced Rewiring of Oncogenic Kinase Triggers Apoptosis.

ACS central science·2026
Same author

Structure-based discovery of selective vaccinia-related kinase 1 inhibitors and fluorogenic active-site probes.

The Journal of biological chemistry·2026
Same author

Time-Resolved "Barbecue" Förster Resonance Energy Transfer for Sensitive and Homogenous Detection of Alginate.

Analytical chemistry·2025
Same author

Spatial Profiling of Elements through Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging.

Analytical chemistry·2025
Same author

Disruption of P. falciparum amino acid transporter elevates intracellular proline and induces resistance to Prolyl-tRNA synthetase inhibitors.

Cell chemical biology·2025
Same journal

Medicinal Chemistry Perspectives on Molecular Targets and Targeted Therapeutic Strategies in Breast Cancer.

Mini reviews in medicinal chemistry·2026
Same journal

Herbal Extract-loaded Biomaterials for Bone Regeneration: Mechanisms of Action, Delivery Platform Optimization, and Translational Considerations.

Mini reviews in medicinal chemistry·2026
Same journal

Ferrocene-based Drug Molecules in Medicinal Chemistry: Comprehensive Insights into their Chemistry, Pharmacology, and Emerging Therapeutic Applications.

Mini reviews in medicinal chemistry·2026
Same journal

PROTAC-Mediated Targeting of PARP via CRBN: Mechanistic Insights, Resistance Challenges, and Therapeutic Advancements.

Mini reviews in medicinal chemistry·2026
Same journal

Recent Advancements in the Development of Heterocyclic Scaffolds as Potential Anti-cancer Agents Targeting EGFR and VEGFR-2.

Mini reviews in medicinal chemistry·2026
Same journal

Exploring the Anticancer Potential of Synthetic β-Carboline Derivatives: A Comprehensive Systematic Review.

Mini reviews in medicinal chemistry·2026
See all related articles

Peptidomimetics offer a novel strategy for inhibiting pathological angiogenesis, a key factor in diseases like cancer and diabetic retinopathy. This review explores their potential in developing new anti-angiogenic therapies.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Drug Discovery

Background:

  • Angiogenesis, the formation of new blood vessels, is crucial for development and healing.
  • Aberrant angiogenesis drives diseases such as diabetic retinopathy, rheumatoid arthritis, and tumor growth.
  • Targeting angiogenesis is a key strategy for treating these pathologies.

Purpose of the Study:

  • To review the application of peptidomimetics in inhibiting pathological angiogenesis.
  • To highlight specific aspects of angiogenesis where peptidomimetics are effective.
  • To discuss current progress in the development of peptidomimetic-based anti-angiogenic drugs.

Main Methods:

  • Literature review focusing on peptidomimetics and angiogenesis.
  • Analysis of studies employing peptidomimetics to inhibit angiogenesis.

Related Experiment Videos

  • Survey of current research and advancements in the field.

    • Main Results:

    • Peptidomimetics show promise as inhibitors of pathological angiogenesis.
    • Specific mechanisms and targets within angiogenesis are amenable to peptidomimetic intervention.
    • The field is advancing with ongoing research and development.

    Conclusions:

    • Peptidomimetics represent a valuable class of compounds for developing anti-angiogenic therapies.
    • Further research is warranted to fully exploit their therapeutic potential.
    • These agents could lead to novel treatments for angiogenesis-related disorders.